|
rs121912666
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs371409680
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs587780076
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs587781525
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs762846821
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs78378222
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A noncoding polymorphism (rs78378222) in TP53, carried by scores of millions of people, was previously associated with moderate risk of brain tumors and other neoplasms.
|
31699989 |
2019 |
|
rs121913500
|
|
|
0.790 |
GeneticVariation |
BEFREE |
A total of 343 brain tumors were studied for IDH1 and IDH2 mutations by direct sequencing and for protein expression by immunohistochemistry with mIDH1(R132H) antibody.
|
21643842 |
2011 |
|
rs118101777
|
|
|
0.020 |
GeneticVariation |
BEFREE |
A total of 343 brain tumors were studied for IDH1 and IDH2 mutations by direct sequencing and for protein expression by immunohistochemistry with mIDH1(R132H) antibody.
|
21643842 |
2011 |
|
rs55819519
|
|
|
0.020 |
GeneticVariation |
BEFREE |
A total of 343 brain tumors were studied for IDH1 and IDH2 mutations by direct sequencing and for protein expression by immunohistochemistry with mIDH1(R132H) antibody.
|
21643842 |
2011 |
|
rs3212227
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, gene-gene interactions of IL-12A rs2243115 and IL-12B rs3212227 may contribute to brain tumor susceptibility.
|
22011063 |
2012 |
|
rs113488022
|
|
|
0.800 |
GeneticVariation |
BEFREE |
Among brain tumors, the BRAF (V600E) mutation is frequently associated with pleomorphic xanthoastrocytomas (PXAs) and gangliogliomas (GGs).
|
26264609 |
2015 |
|
rs121913377
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Among brain tumors, the BRAF (V600E) mutation is frequently associated with pleomorphic xanthoastrocytomas (PXAs) and gangliogliomas (GGs).
|
26264609 |
2015 |
|
rs113488022
|
|
|
0.800 |
GeneticVariation |
BEFREE |
An activating mutation of BRAF (BRAF-V600E) has been reported in a subset of malignant brain tumors.
|
24721513 |
2014 |
|
rs121913377
|
|
|
0.100 |
GeneticVariation |
BEFREE |
An activating mutation of BRAF (BRAF-V600E) has been reported in a subset of malignant brain tumors.
|
24721513 |
2014 |
|
rs121913500
|
|
T |
0.790 |
GeneticVariation |
CLINVAR |
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.
|
23558169 |
2013 |
|
rs113488022
|
|
|
0.800 |
GeneticVariation |
BEFREE |
An institutional cohort of 105 brain tumors (51 dysembryoplastic neuroepithelial tumors (DNTs), 14 subependymal giant cell astrocytomas (SEGAs), 12 glioblastoma with neuronal marker expression (GBM-N), and 28 pleomorphic xanthoastrocytomas (PXAs)) from 100 patients were investigated for the presence of BRAF(V600E) by direct sequencing.
|
25346165 |
2015 |
|
rs121913377
|
|
|
0.100 |
GeneticVariation |
BEFREE |
An institutional cohort of 105 brain tumors (51 dysembryoplastic neuroepithelial tumors (DNTs), 14 subependymal giant cell astrocytomas (SEGAs), 12 glioblastoma with neuronal marker expression (GBM-N), and 28 pleomorphic xanthoastrocytomas (PXAs)) from 100 patients were investigated for the presence of BRAF(V600E) by direct sequencing.
|
25346165 |
2015 |
|
rs1802710
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Analysis of 47 brain tumors and 55 lymphomas found that 23 and 29 of them were heterozygous for rs1802710, respectively.
|
15010842 |
2004 |
|
rs2243115
|
|
|
0.020 |
GeneticVariation |
BEFREE |
And, rs2243115 may enhance the risk of brain tumor.
|
28415696 |
2017 |
|
rs113488022
|
|
|
0.800 |
GeneticVariation |
BEFREE |
Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors.
|
24823863 |
2014 |
|
rs121913377
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors.
|
24823863 |
2014 |
|
rs113488022
|
|
|
0.800 |
GeneticVariation |
BEFREE |
BRAF V600E-mutations have been described in a modest 6% to 7% of primary central nervous system (CNS) tumors, but with increased prevalence in the pediatric population and in certain brain tumor subtypes.
|
24725538 |
2014 |
|
rs121913377
|
|
|
0.100 |
GeneticVariation |
BEFREE |
BRAF V600E-mutations have been described in a modest 6% to 7% of primary central nervous system (CNS) tumors, but with increased prevalence in the pediatric population and in certain brain tumor subtypes.
|
24725538 |
2014 |
|
rs1052576
|
|
|
0.010 |
GeneticVariation |
BEFREE |
CASP-9 (rs1052576) mutant A allele seems to be a protective factor for glioma brain tumor.
|
28870924 |
2017 |
|
rs121913500
|
|
|
0.790 |
GeneticVariation |
BEFREE |
Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.
|
19903171 |
2010 |